Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
Pediatric Nephrology (Berlin, Germany)
|
June 18, 1998
Low levels of serum erythropoietin in children with endemic hemolytic uremic syndrome
R Exeni, H Donato, P Rendo, et al.
Journal of Pediatric Hematology/Oncology
|
March 21, 2002
Alpha-interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura
H Donato, R Kohan, A Picón, et al.
Pediatrics
|
May 3, 2000
Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial
H Donato, N Vain, P Rendo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease
S Pavlovsky, E Schvartzman, F Lastiri, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
Pediatric Nephrology (Berlin, Germany)
|
June 18, 1998
Low levels of serum erythropoietin in children with endemic hemolytic uremic syndrome
R Exeni, H Donato, P Rendo, et al.
Journal of Pediatric Hematology/Oncology
|
March 21, 2002
Alpha-interferon therapy induces improvement of platelet counts in children with chronic idiopathic thrombocytopenic purpura
H Donato, R Kohan, A Picón, et al.
Pediatrics
|
May 3, 2000
Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial
H Donato, N Vain, P Rendo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 1, 1997
Randomized trial of CVPP for three versus six cycles in favorable-prognosis and CVPP versus AOPE plus radiotherapy in intermediate-prognosis untreated Hodgkin's disease
S Pavlovsky, E Schvartzman, F Lastiri, et al.
Page
of 3